多汗症治療の世界市場レポート 2025年

多汗症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.2％で21億3,000万米ドルに成長します。予測期間の成長は、患者中心の治療アプローチ、世界の健康意識、局所療法の進歩、外科的処置の革新、包括的な皮膚科診療への取り込みに起因すると考えられます。予測期間の主な動向としては、個別化治療アプローチ、医療機器の技術革新、経口薬の研究開発、診察や経過観察のための遠隔医療、共同研究やパートナーシップなどが挙げられます。

糖尿病有病率の上昇は、今後数年間の多汗症治療市場の成長を牽引すると予想されます。糖尿病は、体内でインスリンが十分に分泌されないか、インスリンに適切に反応しない場合に発症し、血糖値（グルコース）の上昇を招く。この状態は、汗腺をコントロールする神経を損傷し、過剰な発汗や多汗症につながる可能性があります。糖尿病はまた、体温調節や冷却に必要な量の汗を出す能力にも影響を及ぼします。例えば、2024年3月、英国の健康改善・格差対策室は、2022年3月から2023年3月の間に、推奨される8つのケアプロセスをすべて受けた1型糖尿病患者が22％増加したと報告しました。さらに、2型糖尿病では21％増加し、HbA1cの目標値を達成した人の割合は37.9％に達し、全国糖尿病監査（NDA）が報告した中で過去最高となりました。このように、糖尿病有病率の増加が多汗症治療市場の拡大に寄与しています。

ヘルスケア支出の増加は、今後数年間の多汗症治療市場の成長を促進すると予想されます。ヘルスケア支出とは、医療費、機器、消耗品、医薬品を含む医療財・サービスへの支出を指します。ヘルスケア支出が増加するにつれて、多汗症のような症状や、患者の日常生活や全体的な生活の質への影響に対する認識も高まっています。これには、新しい治療法の開発、外科手術、関連する併存疾患の管理などが含まれます。例えば、2022年3月、メディケア＆メディケイドサービスセンター（CMS）は、2021-2030年国民医療費（NHE）報告書を発表し、国民医療費は毎年平均5.1％増加し、2030年には約6兆8,000億米ドルに達すると予測しました。さらに、メディケア支出は年率7.2％増、メディケイド支出は同期間に年率5.6％増と予測されています。ヘルスケア支出の増加に伴い、多汗症治療市場の拡大が見込まれます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界多汗症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の多汗症治療市場：成長率分析
• 世界の多汗症治療市場の実績：規模と成長, 2019-2024
• 世界の多汗症治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界多汗症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の多汗症治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所治療
• 外科的治療
• ボツリヌス毒素A
• イオントフォレシス
• レーザー治療
• その他の治療法
• 世界の多汗症治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 注射可能
• 世界の多汗症治療市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腋窩多汗症
• 手のひらの多汗症
• 足底多汗症
• その他の病気
• 世界の多汗症治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• 小売薬局
• オンライン
• 世界の多汗症治療市場、局所治療の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 塩化アルミニウム溶液
• 制汗剤
• 世界の多汗症治療市場、外科的治療の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 交感神経切除術
• 切除
• 世界の多汗症治療市場、ボツリン毒素Aのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射治療
• 併用療法
• 世界の多汗症治療市場、イオントフォレシスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホームデバイス
• 臨床機器
• 世界の多汗症治療市場、レーザー治療の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• マイクロ波療法
• レーザーアブレーション
• 世界の多汗症治療市場、その他の治療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口薬
• 代替療法

第7章 地域別・国別分析

• 世界の多汗症治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の多汗症治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 多汗症治療市場：競合情勢
• 多汗症治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
  • GSK plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Cynosure LLC
• Ipsen SA
• Galderma S.A.
• Merz Pharma GmbH & Co. KGaA
• Daewoong Pharmaceutical Co. Ltd.
• Supernus Pharmaceuticals Inc
• Kaken Pharmaceutical Co Ltd
• Avanor Healthcare Ltd.
• HUGEL Inc.
• Evolus Inc.
• Revance Therapeutics Inc.
• Dermira Inc.
• Sesderma SL

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 多汗症治療市場2029：新たな機会を提供する国
• 多汗症治療市場2029：新たな機会を提供するセグメント
• 多汗症治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Hyperhidrosis is a medical condition characterized by excessive sweating beyond what is necessary for regulating the body's temperature. It can affect various areas of the body, such as the underarms, palms, and soles of the feet. Hyperhidrosis treatment involves medical interventions and therapies designed to alleviate or manage the symptoms associated with excessive sweating, aiming to enhance the quality of life for individuals affected by this condition.

The primary types of hyperhidrosis treatments include topical treatments, surgical interventions, botulinum toxin A injections, iontophoresis, laser treatments, and other therapeutic approaches. Topical treatments involve the application of agents directly to the skin to address hyperhidrosis symptoms. Surgical treatments may be considered for certain cases, and botulinum toxin A injections are utilized to reduce excessive sweating. Iontophoresis and laser treatments are additional methods used to manage hyperhidrosis. These treatments can be administered through various routes, including oral and injectable, to address specific types of hyperhidrosis, such as axillary, palmar, plantar, and others. Hyperhidrosis treatments are available through different distribution channels, including hospitals, ambulatory surgical centers, retail pharmacies, and online platforms.

The hyperhidrosis treatment market research report is one of a series of new reports from The Business Research Company that provides hyperhidrosis treatment market statistics, including hyperhidrosis treatment industry global market size, regional shares, competitors with a hyperhidrosis treatment market share, detailed hyperhidrosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the hyperhidrosis treatment industry. This hyperhidrosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hyperhidrosis treatment market size has grown strongly in recent years. It will grow from $1.58 billion in 2024 to $1.67 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to cosmetic concerns, psychosocial impact awareness, regulatory support.

The hyperhidrosis treatment market size is expected to see strong growth in the next few years. It will grow to $2.13 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to patient-centric treatment approaches, global health awareness, advancements in topical therapies, innovations in surgical procedures, inclusion in comprehensive dermatology practices. Major trends in the forecast period include personalized treatment approaches, technological innovations in medical devices, research and development in oral medications, telemedicine for consultations and follow-ups, collaborations and partnerships.

The rising prevalence of diabetes mellitus is expected to drive the growth of the hyperhidrosis treatment market in the coming years. Diabetes mellitus occurs when the body either does not produce enough insulin or does not respond properly to it, leading to elevated blood sugar (glucose) levels. This condition can damage the nerves that control sweat glands, leading to excessive sweating or hyperhidrosis. Diabetes also affects the body's ability to regulate temperature and produce the necessary amount of sweat for cooling. For example, in March 2024, the Office for Health Improvement & Disparities in the UK reported a 22% increase in individuals with type 1 diabetes receiving all eight recommended care processes between March 2022 and March 2023. Additionally, for type 2 diabetes, the percentage rose by 21%, while the percentage of individuals achieving target HbA1c levels reached 37.9%, the highest ever reported by the National Diabetes Audit (NDA). As such, the growing prevalence of diabetes mellitus is contributing to the expansion of the hyperhidrosis treatment market.

Rising healthcare expenditures are expected to fuel the growth of the hyperhidrosis treatment market in the coming years. Healthcare expenditure refers to the spending on medical goods and services, including medical expenses, equipment, supplies, and pharmaceuticals. As healthcare spending increases, so does awareness of conditions like hyperhidrosis and its impact on patients' daily lives and overall quality of life. This includes the development of new treatment options, surgical procedures, and the management of related comorbidities. For instance, in March 2022, the Centers for Medicare & Medicaid Services (CMS) published the 2021-2030 National Health Expenditure (NHE) report, which predicted that national health spending would rise by an average of 5.1% annually, reaching approximately $6.8 trillion by 2030. Furthermore, Medicare expenditures are expected to grow at an annual rate of 7.2%, while Medicaid spending is projected to increase by 5.6% annually over the same period. As healthcare spending rises, it is expected to drive the expansion of the hyperhidrosis treatment market.

Key players within the hyperhidrosis treatment market are intensifying their efforts to introduce wipe formulations, strategically aiming to boost market revenues. Wipe formulations serve as a delivery method for applying medications or antiperspirants to the skin through pre-moistened wipes. These formulations effectively apply antiperspirant medication to alleviate excessive sweating. An illustration of this strategy can be seen with Maruho Co. Ltd.'s May 2022 launch of Rapifort Wipes 2.5% in Japan. These wipes feature glycopyrronium tosilate hydrate as an active component, reducing sweat production by impeding the activation of acetylcholine receptors in sweat glands. Application of this medication solution once daily to both underarms with a single-use non-woven cloth in each packet minimizes sweating. This convenient, hygienic single-use wipe addresses primary axillary hyperhidrosis, a condition characterized by unexplained excessive underarm sweating that can disrupt daily activities.

In June 2023, miraDry Inc., a United States-based company specializing in non-invasive hyperhidrosis treatment, entered into a partnership with the International Hyperhidrosis Society (IHhS). This collaboration is designed to facilitate cooperation between miraDry and the International Hyperhidrosis Society (IHhS) in order to enhance hyperhidrosis therapy. The partnership underscores miraDry's commitment to improving the lives of individuals experiencing excessive sweating. The International Hyperhidrosis Society (IHhS) is a non-profit organization based in the United States that serves millions of individuals affected by hyperhidrosis.

Major companies operating in the hyperhidrosis treatment market report are Pfizer Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, GSK PLC, Teva Pharmaceutical Industries Ltd., Mylan N.V., Cynosure LLC, Ipsen SA, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Daewoong Pharmaceutical Co. Ltd., Supernus Pharmaceuticals Inc., Kaken Pharmaceutical Co Ltd., Avanor Healthcare Ltd., HUGEL Inc., Evolus Inc., Revance Therapeutics Inc., Dermira Inc., Sesderma SL, Miramar Labs Inc., Dermavant Sciences Inc., Theravida Inc., SweatBlock, Brickell Biotech Inc., Fresh Tracks Therapeutics Inc., Advin Health Care Inc., Dermadry Laboratories Inc., Ulthera Inc., Dermata Therapeutics Inc.

North America was the largest region in the hyperhidrosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperhidrosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hyperhidrosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hyperhidrosis treatment market consists of revenues earned by entities by providing services such as microwave therapy, iontophoresis, sympathectomy, and sweat gland removal. The market value includes the value of related goods sold by the service provider or included within the service offering. The hyperhidrosis treatment market also includes sales of drysol, xerac AC, glycopyrrolate, benztropine and beta blockers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hyperhidrosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hyperhidrosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hyperhidrosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hyperhidrosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Topical Treatments; Surgical Treatments; Botulin Toxin A; Iontophoresis; Laser Treatments; Other Treatments
• 2) By Route Of Administration: Oral; Injectable
• 3) By Disease Type: Axillary Hyperhidrosis; Palmar Hyperhidrosis; Plantar Hyperhidrosis; Other Diseases
• 4) By Distribution Channel: Hospitals; Ambulatory Surgical Centers; Retail Pharmacies; Online
• Subsegments:
• 1) By Topical Treatments: Aluminum Chloride Solutions; Antiperspirants
• 2) By Surgical Treatments: Sympathectomy; Excision
• 3) By Botulin Toxin A: Injection Treatments; Combination Therapies
• 4) By Iontophoresis: Home Devices; Clinical Devices
• 5) By Laser Treatments: Microwave Therapy; Laser Ablation
• 6) By Other Treatments: Oral Medications; Alternative Therapies
• Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Sanofi S.A.; AstraZeneca Plc; GSK plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hyperhidrosis Treatment Market Characteristics

3. Hyperhidrosis Treatment Market Trends And Strategies

4. Hyperhidrosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Hyperhidrosis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hyperhidrosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hyperhidrosis Treatment Market Growth Rate Analysis
• 5.4. Global Hyperhidrosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hyperhidrosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hyperhidrosis Treatment Total Addressable Market (TAM)

6. Hyperhidrosis Treatment Market Segmentation

• 6.1. Global Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Treatments
• Surgical Treatments
• Botulin Toxin A
• Iontophoresis
• Laser Treatments
• Other Treatments
• 6.2. Global Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• 6.3. Global Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Axillary Hyperhidrosis
• Palmar Hyperhidrosis
• Plantar Hyperhidrosis
• Other Diseases
• 6.4. Global Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Retail Pharmacies
• Online
• 6.5. Global Hyperhidrosis Treatment Market, Sub-Segmentation Of Topical Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aluminum Chloride Solutions
• Antiperspirants
• 6.6. Global Hyperhidrosis Treatment Market, Sub-Segmentation Of Surgical Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sympathectomy
• Excision
• 6.7. Global Hyperhidrosis Treatment Market, Sub-Segmentation Of Botulin Toxin A, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injection Treatments
• Combination Therapies
• 6.8. Global Hyperhidrosis Treatment Market, Sub-Segmentation Of Iontophoresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Home Devices
• Clinical Devices
• 6.9. Global Hyperhidrosis Treatment Market, Sub-Segmentation Of Laser Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microwave Therapy
• Laser Ablation
• 6.10. Global Hyperhidrosis Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Medications
• Alternative Therapies

7. Hyperhidrosis Treatment Market Regional And Country Analysis

• 7.1. Global Hyperhidrosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hyperhidrosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hyperhidrosis Treatment Market

• 8.1. Asia-Pacific Hyperhidrosis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hyperhidrosis Treatment Market

• 9.1. China Hyperhidrosis Treatment Market Overview
• 9.2. China Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hyperhidrosis Treatment Market

• 10.1. India Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hyperhidrosis Treatment Market

• 11.1. Japan Hyperhidrosis Treatment Market Overview
• 11.2. Japan Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hyperhidrosis Treatment Market

• 12.1. Australia Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hyperhidrosis Treatment Market

• 13.1. Indonesia Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hyperhidrosis Treatment Market

• 14.1. South Korea Hyperhidrosis Treatment Market Overview
• 14.2. South Korea Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hyperhidrosis Treatment Market

• 15.1. Western Europe Hyperhidrosis Treatment Market Overview
• 15.2. Western Europe Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hyperhidrosis Treatment Market

• 16.1. UK Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hyperhidrosis Treatment Market

• 17.1. Germany Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hyperhidrosis Treatment Market

• 18.1. France Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hyperhidrosis Treatment Market

• 19.1. Italy Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hyperhidrosis Treatment Market

• 20.1. Spain Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hyperhidrosis Treatment Market

• 21.1. Eastern Europe Hyperhidrosis Treatment Market Overview
• 21.2. Eastern Europe Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hyperhidrosis Treatment Market

• 22.1. Russia Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hyperhidrosis Treatment Market

• 23.1. North America Hyperhidrosis Treatment Market Overview
• 23.2. North America Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hyperhidrosis Treatment Market

• 24.1. USA Hyperhidrosis Treatment Market Overview
• 24.2. USA Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hyperhidrosis Treatment Market

• 25.1. Canada Hyperhidrosis Treatment Market Overview
• 25.2. Canada Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hyperhidrosis Treatment Market

• 26.1. South America Hyperhidrosis Treatment Market Overview
• 26.2. South America Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hyperhidrosis Treatment Market

• 27.1. Brazil Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hyperhidrosis Treatment Market

• 28.1. Middle East Hyperhidrosis Treatment Market Overview
• 28.2. Middle East Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hyperhidrosis Treatment Market

• 29.1. Africa Hyperhidrosis Treatment Market Overview
• 29.2. Africa Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hyperhidrosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hyperhidrosis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Hyperhidrosis Treatment Market Competitive Landscape
• 30.2. Hyperhidrosis Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GSK plc Overview, Products and Services, Strategy and Financial Analysis

31. Hyperhidrosis Treatment Market Other Major And Innovative Companies

• 31.1. Teva Pharmaceutical Industries Ltd.
• 31.2. Mylan N.V.
• 31.3. Cynosure LLC
• 31.4. Ipsen SA
• 31.5. Galderma S.A.
• 31.6. Merz Pharma GmbH & Co. KGaA
• 31.7. Daewoong Pharmaceutical Co. Ltd.
• 31.8. Supernus Pharmaceuticals Inc
• 31.9. Kaken Pharmaceutical Co Ltd
• 31.10. Avanor Healthcare Ltd.
• 31.11. HUGEL Inc.
• 31.12. Evolus Inc.
• 31.13. Revance Therapeutics Inc.
• 31.14. Dermira Inc.
• 31.15. Sesderma SL

32. Global Hyperhidrosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hyperhidrosis Treatment Market

34. Recent Developments In The Hyperhidrosis Treatment Market

35. Hyperhidrosis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Hyperhidrosis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hyperhidrosis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hyperhidrosis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer